Correction: Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect.
Where this comes from
- Record sourced from PubMed, PMID 40367037.
- Also identified by DOI 10.1371/journal.pone.0324192 and PMC identifier 12077689.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0319686.].